drugset / Trial / NCT04141319

Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Post-craniotomy Pain

NCT04141319

Phase 4 Unknown 100 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

The PAINLESS study is a single-center, prospective, randomized, open-label, blinded-endpoint (PROBE) controlled clinical study to compare the efficacy and safety of pre-emptive scalp infiltration with ropivacaine plus ketorolac and ropivacaine alone for postoperative pain relief in adults undergoing elective supratentorial craniotomies.

Timeline

Start
2021-12
Primary completion
2022-07
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 6 mg Other
Background Epinephrine Other / unclassified 0.1 mg Other
Background Ropivacaine Other / unclassified 60 mg Other

Indications